Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:A 29-Year-Old Fund Is Transformed to Fight Cancer Not Rated 5.0 Email Routing List Email & Route  Print Print
Tuesday, September 17, 2024

A 29-Year-Old Fund Is Transformed to Fight Cancer

Reported by Neil Anderson, Managing Editor

The team at a publicly traded, $361-billion-AUM (as of June 30), 2,000-employee, multinational asset manager are transforming a 29-year-old mutual fund as part of a pledge to support a charity that fights cancer via research, patient support, and advocacy.

Ali Dibadj
Janus Henderson Investors
CEO, Board Member
Yesterday, Ali Dibadj, CEO of Janus Henderson [profile], and Karen Knudsen, CEO of the American Cancer Society, unveiled a new partnership involving a Janus Henderson donating some fees generated by a longstanding mutual fund, the Janus Henderson Government Money Market Fund. The partnership is part of Janus Henderson's Brighter Future project.

Per the new ACS partnership, Janus Henderson has agreed to set aside half of the money fund's management fees each quarter and donate that half to the ACS. The fund firm has promised to donate at least $1 million per year for at least three years. (In contrast to another cancer-focused fund-charity relationship, this new partnership doesn't involve the charity taking an ownership stake in fund firm, though.)

Along with the ACS partnership, the Janus Henderson has revamped the Janus Henderson Government Money Market Fund's two share classes, effective September 4. D shares (for direct sale to individual investors) are now called "American Cancer Society Support - Class D Shares," their ticker switched from JGVXX to ACDXX, and their expense ratio remains 58 basis points. T shares (fka J shares) (available through certain intermediaries) are now called "American Cancer Soceity Support - Class T Shares," their ticker switched from JAGXX to ACTXX, and their expense ratio rermains 60bps. (The share class now known as T shares is the fund's original share class, and its inception date was February 14, 1995. D shares launched on February 16, 2010.)

Within the expense ratios for ACTXX and ACDXX, the management fee is the same: 20bps. Thus, Janus Henderson's pledge amounts to a promise to donate 10bps from the money fund's AUM (starting at a minimum of $1 million per year). As of August 31, 2024, the fund had $401.13 million in AUM. (If the fund surpasses $50 billion in AUM, an increase of more than a hundred fold, the Janus Henderson team says they will lower the percentage donated to ACS.)

"It's our sincere hope this partnership will help create a brighter future for many," Dibadj states. "Among cancer's many impacts, the financial burden of a diagnosis can be devastating."

"Through this initiative, Janus Henderson and our clients can now easily support ACS' critical work in advocacy, research, and patient suppot, helping to improve the lives of both cancer patients and their families," Dibadj adds.

Knudsen calls ACS' new Janus Henderson partnership an "innovative fundraising method."

"Their generous support will increase our ability to fund groundbreaking research, advocate for better access to care at the federal and local levels, and provide direct patient support to help us end cancer as we know it, for everyone," Knudsen states.

Janus Henderson Investors US LLC serves as investment advisor to ACDXX and ACTXX. The fund's PM team includes: Vincent Ahn, executive vice president and co-portfolio manager since December 2022; and Garrett Strum, EVP and co-PM since May 2017.

ACTXX and ACDXX's other service providers include: BNP Paribas as custodian; Janus Henderson Distributors US LLC as distributor; and Janus Henderson Services US LLC as transfer agent. 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

5.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q4Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. IDC Foundations for Fund Directors, Dec 4-5
  2. WE Boston - Women's Initiative Joint Holiday Networking Reception, December 4
  3. WE South - Wine Wednesday Holiday Celebration, December 4
  4. Nicsa webinar - Post-Election Insights: Impact on Global Policies, Markets, and Regulations, December 4
  5. WE Denver - 2024 Annual Holiday Party, December 5
  6. WE Washington D.C. - 2024 Holiday Dinner Event, December 5
  7. MFDF webinar - BDC Board Service 101, December 10
  8. MFDF webinar - ETF Product Trends: Board Implications, December 11
  9. MFDF webinar - Visually Mapping Board Composition: Skills Matrices in Fund Board Rooms, December 18
  10. MFDF webinar - 2024 Fair Valuation Pricing Survey: Building and Strengthening the Valuation Operating Model, January 7, 2025
  11. MFDF webinar - 15(c) White Paper Webinar Series: Part 2 – Board Processes, January 9, 2025
  12. MFDF webinar - AI and Fund Compliance, January 21, 2025
  13. MFDF In Focus - In Focus: Small Boards' Use of Skills Matrices, January 22, 2025
  14. FSI OneVoice 2025, January 27 - 29, 2025
  15. MFDF 2025 Directors' Institute, January 27 - 29, 2025
  16. 2025 ICI Innovate, February 3 - 5, 2025
  17. MFDF Director Discussion Series - Open Forum, February 10, 2025
  18. MFDF Director Discussion Series - Open Forum, February 11, 2025
  19. MFDF 2025 Fund Governance & Regulatory Insights Conference, March 6 - 7, 2025
  20. MFDF Director Discussion Series - Open Forum, April 2, 2025
  21. MFDF Director Discussion Series - Open Forum, April 15, 2025
  22. The 36th Sub-Advised Funds Forum, April 29 - 30, 2025
  23. Morningstar Investment Conference 2025, June 25 - 26, 2025
  24. MFDF Director Discussion Series - Open Forum, July 9, 2025




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use